Difficulty: Medium
Average Score: 79%
Practice
Tick the anticancer alkylating drug, a derivative of ethylenimine:
Correct answer
B
Rationale
In this question, the correct answer is B) Thiotepa. Thiotepa is an anticancer alkylating drug that belongs to the derivative of ethylenimine class. Alkylating agents work by attaching an alkyl group to DNA, which interferes with cell division and ultimately leads to cell death. Thiotepa is commonly used in chemotherapy to treat various types of cancer.
Now let's analyze why the other options are incorrect:
A) Mercaptopurine is a purine analog antimetabolite, not an alkylating agent. It interferes with nucleic acid synthesis by inhibiting enzymes involved in purine metabolism.
C) Chlorambucil is an alkylating agent, but it belongs to the nitrogen mustard class, not the ethylenimine class like Thiotepa.
D) Procarbazine is also an alkylating agent, but it is not a derivative of ethylenimine. It is part of the hydrazine class of alkylating agents.
Educational Context:
Understanding the classification of anticancer drugs is crucial for healthcare professionals, especially those working in oncology and pharmacology. Knowing the mechanisms of action and specific drug classes helps in selecting the most appropriate treatment regimens for cancer patients while minimizing adverse effects. By differentiating between various types of anticancer drugs, healthcare providers can improve patient outcomes and ensure safe and effective chemotherapy administration.
Now let's analyze why the other options are incorrect:
A) Mercaptopurine is a purine analog antimetabolite, not an alkylating agent. It interferes with nucleic acid synthesis by inhibiting enzymes involved in purine metabolism.
C) Chlorambucil is an alkylating agent, but it belongs to the nitrogen mustard class, not the ethylenimine class like Thiotepa.
D) Procarbazine is also an alkylating agent, but it is not a derivative of ethylenimine. It is part of the hydrazine class of alkylating agents.
Educational Context:
Understanding the classification of anticancer drugs is crucial for healthcare professionals, especially those working in oncology and pharmacology. Knowing the mechanisms of action and specific drug classes helps in selecting the most appropriate treatment regimens for cancer patients while minimizing adverse effects. By differentiating between various types of anticancer drugs, healthcare providers can improve patient outcomes and ensure safe and effective chemotherapy administration.